Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, October 18, 2013

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

Biopharmaceutical immuno- oncology company Stem Cell Therapeutics has entered an agreement to exclusively license worldwide rights to a panel of fully human monoclonal antibodies targeting the SIRPa protein .

http://www.news-medical.net/news/20131018/Stem-Cell-Therapeutics-Nabs-Sirpa-Protein-Targeting-Mabs.aspx
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts